2 comments

[ 2.7 ms ] story [ 19.1 ms ] thread
Well that's disappointing, although not definitive.

Another study gave a slightly rosier picture but had no control arm, so it isn't all that useful https://www.nejm.org/doi/full/10.1056/NEJMoa2007016

The Chinese study was apparently stopped early due to declining cases and difficulty of enrolling new participants.

this was from an RCT. the best way to see a difference. obviously gilead is disputing it. But this data trumps any compassionate use data that isn't randomized.